Table 2.
material | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | total |
---|---|---|---|---|---|---|---|---|---|---|---|
number of animals | 10 | 10 | 10 | 10 | 10 | ||||||
subcutaneous (s.c.) sites | 10 | — | 10 | — | 10 | — | 10 | — | 10 | — | 50 |
intramuscular (i.m.) sites | — | 10 | — | 10 | — | 10 | — | 10 | — | 10 | 50 |
visible nodule development (sites) | 0 | 0 | 0 | 0 | 10 | 10 | 0 | 10 | 0 | 0 | 30 |
sacrifice or death (animals) | |||||||||||
4–5 months | 0 | 0 | 3a | 0 | 0 | 3 | |||||
6 months | 4 | 4 | 7b | 4 | 4 | 23 | |||||
8 months | 0 | 0 | 0 | 1a+5b | 0 | 6 | |||||
12 months | 6 | 6 | 0 | 0 | 6 | 18 |
Death of the animal.
Animals were euthanized because of the development of handicapping tumours.